The first is conflating injectable and topical dosing conventions applying an injectable milligram-target approach to a topical protocol that should use concentration-based formulation, or vice versa
When calculating volumes for a specific retatrutide dose, researchers should account for the concentration of the reconstituted solution
For CY 2025, we rebased and revised the 2017-based FQHC market basket to reflect a 2022 base year (89 FR 98023 through 98032)
Food intake does not significantly affect their absorption or effectiveness
Dickinson BL, Claypool SM, DAngelo JA, Aiken ML, Venu N, Yen EH, et al
In the CY 2025 PFS final rule (89 FR 98228 through 98313), to implement sections 11101 and 11102 of the IRA, we codified these requirements and established other policies for the Medicare Part B Drug Inflation Rebate Program and the Medicare Part D Drug Inflation Rebate Program (collectively referred to as the Medicare Prescription Drug Inflation Rebate Program) in regulatory text at parts 427 and 428 under title 42, chapter IV of the Code of Federal Regulations for Part B and Part D, respectively